Albert Pharmaceuticals Private Limited
About Albert Pharmaceuticals Private Limited
Data last updated:
Albert Pharmaceuticals Private Limited is a private limited company based in Gopalganj, Bihar, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 29 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2016PTC025845. Its GSTIN is 10AAOCA1351P1ZO (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arshad Jawed (Managing Director) and Sabira Begam.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at H/O Sabira Begam Holding No. 249 Jangalia Ward No. – 19 Po Distt. – Gopalganj, Bihar, India – 841428.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.43 Lakh, a decline of 49% compared to the previous year. For the same year it recorded a net loss of ₹3.82 Lakh (net margin -157.2%) and EBITDA of -₹3.8 Lakh (EBITDA margin -156.3%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Albert Pharmaceuticals Private Limited's registered office is in Gopalganj, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressH/O Sabira Begam Holding No. 249 Jangalia Ward No. – 19 Po Distt. – Gopalganj, Bihar, India – 841428
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Albert Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Albert Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Albert Pharmaceuticals Private Limited, buy the company report.
Financials of Albert Pharmaceuticals Private Limited
FY 2021 filings availableAlbert Pharmaceuticals Private Limited reported revenue of ₹2.43 Lakh (down 49% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over three years, including a 49% fall in the latest year. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -156.3% | ||||
| Net Profit Margin | -157.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Albert Pharmaceuticals Private Limited, buy the company report.
Board of directors of Albert Pharmaceuticals Private Limited
Albert Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arshad Jawed | Managing Director | 29 Jan 2016 | 10 Years 9 Months | Current |
| Sabira Begam | Director | 29 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Albert Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medesign Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2025) | 6.0% | Delhi, India | |||
| Albert Pharmaceuticals Private Limitedthis company | ₹2.43 Lakh (FY 2021) | -₹3.82 Lakh | -157.2% | -49.0% | Gopalganj, Bihar, India | |
| Emblem Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2025) | -58.0% | Delhi, India | |||
| Evoluent Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2021) | -55.0% | Palace Guttahalli, Karnataka, India | |||
| Omish Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2023) | -93.0% | Delhi, India |
To see the full peer comparison of Albert Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Albert Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Albert Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Albert Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Albert Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Albert Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAOCA1351P1ZO | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Albert Pharmaceuticals Private Limited, buy the company report.
Recent activity
Albert Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Arshad Jawed was appointed as Managing Director on 29 Jan 2016.
Frequently asked questions
Albert Pharmaceuticals is an active private limited company based in Gopalganj, Bihar, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 29 January 2016 (10+ years old) and is registered under CIN U74999BR2016PTC025845.
Albert Pharmaceuticals has 2 current directors:
- Arshad Jawed - Managing Director
- Sabira Begam - Director
The latest financial statements of Albert Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Albert Pharmaceuticals is 10AAOCA1351P1ZO, registered in Bihar.
The CIN (Corporate Identification Number) of Albert Pharmaceuticals is U74999BR2016PTC025845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Albert Pharmaceuticals was incorporated on 29 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Albert Pharmaceuticals by revenue are Medesign Pharmaceuticals Private Limited, Emblem Pharmaceuticals Private Limited, Evoluent Pharmaceuticals Private Limited, Omish Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arshad Jawed was appointed as Managing Director on 29 Jan 2016. Sabira Begam was appointed as Director on 29 Jan 2016.
The registered office of Albert Pharmaceuticals is at HO Sabira Begam Holding No. 249 Jangalia Ward No. – 19 Po Distt. – Gopalganj, Bihar, India – 841428.
Albert Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Albert Pharmaceuticals is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.